These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 30472333

  • 1. Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
    Omaña-Molina M, Vanzzini-Zago V, Hernández-Martínez D, Reyes-Batlle M, Castelan-Ramírez I, Hernández-Olmos P, Salazar-Villatoro L, González-Robles A, Ramírez-Flores E, Servín-Flores C, Flores-Alvarado V, Alcántara-Castro M, Lorenzo-Morales J.
    Exp Parasitol; 2019 Jan; 196():22-27. PubMed ID: 30472333
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
    Hernández-Martínez D, Reyes-Batlle M, Castelan-Ramírez I, Hernández-Olmos P, Vanzzini-Zago V, Ramírez-Flores E, Sifaoui I, Piñero JE, Lorenzo-Morales J, Omaña-Molina M.
    Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
    [Abstract] [Full Text] [Related]

  • 3. Acanthamoeba genotypes T3 and T4 as causative agents of amoebic keratitis in Mexico.
    Omaña-Molina M, Vanzzini-Zago V, Hernandez-Martinez D, Gonzalez-Robles A, Salazar-Villatoro L, Ramirez-Flores E, Oregon-Miranda E, Lorenzo-Morales J, Martinez-Palomo A.
    Parasitol Res; 2016 Feb; 115(2):873-8. PubMed ID: 26581373
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.
    Gueudry J, Le Goff L, Compagnon P, Lefevre S, Colasse E, Aknine C, Duval F, François A, Razakandrainibe R, Ballet JJ, Muraine M, Favennec L.
    J Antimicrob Chemother; 2018 Jul 01; 73(7):1895-1898. PubMed ID: 29596605
    [Abstract] [Full Text] [Related]

  • 5. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole.
    Talbott M, Cevallos V, Chen MC, Chin SA, Lalitha P, Seitzman GD, Lietman TM, Keenan JD.
    Cornea; 2019 Oct 01; 38(10):1309-1313. PubMed ID: 31306283
    [Abstract] [Full Text] [Related]

  • 6. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
    Bang S, Edell E, Eghrari AO, Gottsch JD.
    Am J Ophthalmol; 2010 Jan 01; 149(1):66-9. PubMed ID: 19875089
    [Abstract] [Full Text] [Related]

  • 7. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ, Kilvington S, Hughes R, Tufail A, Matheson M, Dart JK.
    Ophthalmology; 2003 Aug 01; 110(8):1593-600. PubMed ID: 12917179
    [Abstract] [Full Text] [Related]

  • 8. Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear.
    Lee SJ, Jeong HJ, Lee JE, Lee JS, Xuan YH, Kong HH, Chung DI, Ock MS, Yu HS.
    Korean J Parasitol; 2006 Dec 01; 44(4):313-20. PubMed ID: 17170573
    [Abstract] [Full Text] [Related]

  • 9. Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of Acanthamoeba keratitis - a growing threat to human health worldwide.
    Padzik M, Baltaza W, Conn DB, Szaflik JP, Chomicz L.
    Ann Agric Environ Med; 2018 Dec 20; 25(4):725-731. PubMed ID: 30586959
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Virulent T4 Acanthamoeba causing keratitis in a patient after swimming while wearing contact lenses in Southern Brazil.
    Fabres LF, Maschio VJ, Santos DLD, Kwitko S, Marinho DR, Araújo BS, Locatelli CI, Rott MB.
    Acta Parasitol; 2018 Jun 26; 63(2):428-432. PubMed ID: 29654672
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In-vitro development of an effective treatment for Acanthamoeba keratitis.
    Ortillés Á, Belloc J, Rubio E, Fernández MT, Benito M, Cristóbal JÁ, Calvo B, Goñi P.
    Int J Antimicrob Agents; 2017 Sep 26; 50(3):325-333. PubMed ID: 28709990
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis − an emerging sight-threatening corneal disease in Poland.
    Padzik M, Baltaza W, Szaflik JP, Hendiger E, Dybicz M, Chomicz L.
    Ann Parasitol; 2018 Sep 26; 64(3):229-233. PubMed ID: 30316219
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M.
    Eye (Lond); 1996 Sep 26; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.